C106 - Cognitive Impairment Due to Alzheimer's Disease: Using Old Skills and New Tools for Diagnosis and Treatment
| Event Time: | Monday May 6, 2019 3:30 pm to 5:30 pm |
| Topic(s): | Aging, Dementia, Cognitive, and Behavioral Neurology, Foundations in Clinical Neurology for APPs |
| Director(s): | David Knopman MD, FAAN |
| Description: | This program will focus on important topics in the diagnosis of cognitive impairment due to Alzheimer's disease. We will discuss the basics of the clinical diagnosis, the role of genetics in diagnosis and information for patients and families, the role of clinical and experimental imaging in the diagnosis of AD, and where we stand with treatment for AD. |
| Completion Message: | Participants should be able to describe the continuum of cognitive function in the Alzheimer spectrum, understand the major and minor genetic influences on AD, describe the evolving biomarker diagnostic process for defining AD as a pathophysiology, and describe the appropriate indications for cholinesterase inhibitors and memantine. |
| CME Credits: | 2 |
| Core Competencies: | Patient Care, Medical Knowledge |
| Start/End Time | Title | Faculty |
|---|---|---|
| 3:30 PM - 3:35 PM | Introduction | David S. Knopman MD, FAAN |
| 3:35 PM - 4:05 PM | The Clinical Diagnosis of MCI and Dementia Due to AD | Richard J. Caselli MD, FAAN |
| 4:05 PM - 4:30 PM | Biomarkers for the Etiological Diagnosis of AD | David S. Knopman MD, FAAN |
| 4:30 PM - 4:55 PM | The Role for Genetics in AD Diagnosis and Management | Richard J. Caselli MD, FAAN |
| 4:55 PM - 5:15 PM | Therapeutics in AD for 2019 | David S. Knopman MD, FAAN |
| 5:15 PM - 5:30 PM | Questions and Answers | Faculty |
| Speaker | Disclosure |
|---|---|
| Richard J. Caselli, MD, FAAN | Dr. Caselli has nothing to disclose. |
| David S. Knopman, MD, FAAN | Dr. Knopman has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Washington University for the DIAN study. Dr. Knopman has received research support from Biogen Pharmaceuticals and Lilly Pharmaceuticals. |
Ready to register for the 2019 AAN Annual Meeting?
Related Courses
| 7:00 AM-9:00 AM |
|---|
|
C247 -
What Do I Do Now?: Emergency and Inpatient Management of Migraine and Other Headache Disorders
Stephanie Nahas MD, FAAN |
| 9:15 AM-11:30 AM |
|
Neurology Year in Review Plenary Session
Martinson Arnan MD |
| 1:00 PM-3:00 PM |
|
C252 -
Update in Aging and Dementia
Gil Rabinovici MD |
| 3:30 PM-4:30 PM |
|
C255 -
Education Blitz: Normal Pressure Hydrocephalus
Neill Graff-Radford MD, FAAN |